BR0014052A - Amine derivatives - Google Patents

Amine derivatives

Info

Publication number
BR0014052A
BR0014052A BR0014052-0A BR0014052A BR0014052A BR 0014052 A BR0014052 A BR 0014052A BR 0014052 A BR0014052 A BR 0014052A BR 0014052 A BR0014052 A BR 0014052A
Authority
BR
Brazil
Prior art keywords
amine derivatives
ring
solvates
inhibition
therapy
Prior art date
Application number
BR0014052-0A
Other languages
Portuguese (pt)
Inventor
Volker Eiermann
Rochus Jonas
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0014052A publication Critical patent/BR0014052A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "DERIVADOS DE AMINAS". e seus sais e solvatos fisiologicamente aceitáveis, em que R^ 1^, R^ 2^, R^ 8^, R^ 9^, R^ 10^, R^ 11^, Q, X, Y, Z, r, o anel A e o anel C têm as definições estabelecidas na reivindicação 1, apresentam inibição de fosfodiesterase V e podem ser utilizados para tratar distúrbios do sistema cardiovascular e para o tratamento e/ou terapia da potência prejudicada.Invention Patent: "AMIN DERIVATIVES". and their physiologically acceptable salts and solvates, where R ^ 1 ^, R ^ 2 ^, R ^ 8 ^, R ^ 9 ^, R ^ 10 ^, R ^ 11 ^, Q, X, Y, Z, r, ring A and ring C have the definitions set out in claim 1, exhibit phosphodiesterase V inhibition and can be used to treat disorders of the cardiovascular system and for the treatment and / or therapy of impaired potency.

BR0014052-0A 1999-09-17 2000-08-24 Amine derivatives BR0014052A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944604A DE19944604A1 (en) 1999-09-17 1999-09-17 Amine derivatives
PCT/EP2000/008256 WO2001021620A2 (en) 1999-09-17 2000-08-24 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines

Publications (1)

Publication Number Publication Date
BR0014052A true BR0014052A (en) 2002-05-21

Family

ID=7922374

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014052-0A BR0014052A (en) 1999-09-17 2000-08-24 Amine derivatives

Country Status (11)

Country Link
EP (1) EP1212329A2 (en)
JP (1) JP2003509511A (en)
KR (1) KR20020027652A (en)
AU (1) AU7412700A (en)
BR (1) BR0014052A (en)
CA (1) CA2387520A1 (en)
CZ (1) CZ2002817A3 (en)
DE (1) DE19944604A1 (en)
NO (1) NO20021310D0 (en)
PL (1) PL353319A1 (en)
WO (1) WO2001021620A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148883A1 (en) * 2001-10-04 2003-04-10 Merck Patent Gmbh New fused bi- or tricyclic pyrimidine derivatives, are phosphodiesterase V inhibitors useful e.g. for treating impotence, cardiovascular disorders, inflammation or tumors
JPWO2003035653A1 (en) * 2001-10-26 2005-02-10 日本曹達株式会社 Pyridothienopyrimidine compounds and salts thereof
AR059901A1 (en) 2006-03-20 2008-05-07 Bayer Pharmaceuticals Corp USEFUL TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS TO TREAT OR PREVENT CELLULAR PROLIFERATIVE DISORDERS.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470356A1 (en) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K New thieno [3,2-d] pyrimidines and process for their preparation
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (en) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidines
DE19819023A1 (en) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidines
US5948911A (en) * 1998-11-20 1999-09-07 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
AU3453900A (en) * 1999-03-30 2000-10-23 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE19928146A1 (en) * 1999-06-19 2000-12-21 Merck Patent Gmbh New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence

Also Published As

Publication number Publication date
CA2387520A1 (en) 2001-03-29
CZ2002817A3 (en) 2002-06-12
WO2001021620A3 (en) 2001-11-01
NO20021310L (en) 2002-03-15
WO2001021620A2 (en) 2001-03-29
JP2003509511A (en) 2003-03-11
DE19944604A1 (en) 2001-03-22
PL353319A1 (en) 2003-11-17
AU7412700A (en) 2001-04-24
NO20021310D0 (en) 2002-03-15
KR20020027652A (en) 2002-04-13
EP1212329A2 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
BR9712321A (en) Aminothiophenocarboxamides
BR9901491A (en) 7-hetero-bicycles [2.2.1] - heptanes.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BR9815409A (en) Thienopyrimidines
NO20050807L (en) Pharmaceutical compositions including dextromethorphan and quinidine for the treatment of neurological disorders
BR0109272A (en) Therapeutic conjugate agents of polyglutamic acid, methods for their preparation and uses
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
BR0309875A (en) methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor
MY103352A (en) Piperazinyl-heterocyclic compounds
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
BR0014381A (en) Derivatives of 5-beta-sapogenin and pseudosapogenin and their use in the treatment of dementia
BR0210652A (en) Pyrrolopyrimidines as protein kinase inhibitors
BR0209153A (en) Indole, azaindole and related heterocyclic amidopiperazine derivatives
BR0313732A (en) Pyrimide compounds having antiproliferative activity
GB0005251D0 (en) Therapeutic compounds
BR9814592A (en) "azopolycyclic compounds condensed with aryl"
HK1050899A1 (en) Pteridine compounds for the treatment of psoriasis
AP9701041A0 (en) Pyridylpyrrole compounds.
BR0011778A (en) Thienopyrimidines
BR0312232A (en) Caspase inhibitors and their uses
BR0013781A (en) Pyrazolo [4,3-d] pyrimidines
MXPA03010761A (en) Pharmaceutical combinations.
BR0113291A (en) aporphine esters and their use in therapy
BR0014355A (en) Sapogenin derivatives and their use in the treatment of cognitive dysfunction
BR9910032A (en) Thienopyrimidines

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]